ASX ANNOUNCEMENT Lumos Secures Distribution for FebriDx® in Portugal MELBOURNE, Australia (19 November 2026) – Lumos Diagnostics Holdings Ltd (ASX:LDX, “Lumos” or the “Company”) a leader in rapid, point-of-care diagnostic technologies, is pleased to announce that it has executed a new...
Lumos Secures Distribution for FebriDx in Portugal
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Lumos Diagnostics Holdings Ltd. has announced a new distribution agreement for FebriDx in Portugal with Magnamed LDA. Magnamed is a medical device distributor that supplies various healthcare facilities in Portugal. This partnership aims to enhance access to FebriDx across the Portuguese market, leveraging Magnamed's established logistics and customer relationships. Lumos is expanding its European distribution network, with existing agreements in several countries already in place.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Lumos Diagnostics Holdings Ltd. on 6ix
Story so far
Earlier from Lumos Diagnostics
- Results of Annual General Meeting
- 2026 AGM Presentation
- AGM Chair Address
- Lumos Expands FebriDx Adoption Across WellStreet Locations
- Investor Presentation
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics